Low bone mineral density in a case of mosaicism Klinefelter syndrome: Rapid response to testosterone therapy

Endocrine Journal

Volumn 45, Issue 4, 1998, Pages 601-604

  Yamauchi, Mika ^a   Tadano, Makoto ^a   Fukunaga, Yasutomo ^a   Inoue, Daisuke ^a   Minamikawa, Jun ^a   Koshiyama, Hiroyuki ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

Diabetes mellitus; Klinefelter syndrome; Mosaicism; Osteoporosis; Testosterone treatment

Indexed keywords

ALFACALCIDOL; C PEPTIDE; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; HEMOGLOBIN A1C; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CASE REPORT; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HYPOGONADOTROPIC HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KLINEFELTER SYNDROME; MALE; MALE INFERTILITY; MOSAICISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PHYSICAL EXAMINATION; TESTOSTERONE BLOOD LEVEL;

EID: 0031751815     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.601     Document Type: Article

References (18)

1. Jackson JA, Kleerekoper M (1990) Osteoporosis in men: Diagnosis, pathophysiology, and prevention. Medicine 69: 137-152.
2. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF (1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106: 354-361.
3. Khosla S, Melton III LJ (1995) Secondary osteoporosis. In: Riggs BL, Melton III LJ (eds) Osteoporosis: Etiology, Diagnosis and Management. 2nd ed, Lippincott-Raven, New York, 183-204.
4. Kleerekoper M (1995) Extensive personal experience: The clinical evaluation and management of osteoporosis. J Clin Endocrinol Metab 80: 757-763.
5. Koshiyama H, Koh T, Sone T (1994) Therapeutic dilemma with thyroxine replacement in hypothyroidism (letter). Arch Intern Med 154: 1997.
6. Koshiyama H, Sone T, Nakao K (1995) Vitamin-D-receptor-gene polymorphism and bone loss (letter). Lancet 345: 990-991.
7. Fukunaga Y, Minamikawa J, Inoue D, Koshiyama H (1997) Does insulin increase bone mineral density in non-insulin-dependent diabetes mellitus? (letter) Arch Intern Med 157: 2668-2669.
8. Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BEC (1992) Osteoporosis and Kleinefelte's syndrome. Clin Endocrinol 36: 113-118.
9. Bhasin S, Bremner WJ (1997) Emerging issues in androgen replacement therapy. J Clin Endocrinol Metab 82: 3-8.
10. Nakano Y, Morimoto I, Ishida O, Fujihira T, Mizokami A, Tanimoto A, Yanagihara N, Izumi F, Eto S (1994) The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone and Mineral 26: 245-259.
11. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelberg TC (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86: 854-857.
12. Fukayama S, Tashjian Jr AH (1989) Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 125: 1789-1794.
13. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331: 1056-1061.
14. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337: 91-95.
15. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley Jr WF (1989) Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69: 776-783.
16. Bhasin S, Stopper TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnel TJ, Casaburi R (1997) Testosterone replacement increases fat-free mass and muscle size in hypogonadal man. J Clin Endocrinol Metab 82: 407-413.
17. Guo G-C, Jones TH, Eastell R (1997) Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 82: 658-665.
18. Beher HM, Kliesch S, Leifke E, Link TM, Nieschlag E (1997) Long-term effect of tesosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82: 2386-2390.